Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma

Abstract Background Uterine corpus endometrial carcinoma (UCEC) is a frequent gynecological malignancy with a poor prognosis particularly at an advanced stage. Herein, this study aims to construct prognostic markers of UCEC based on immune-related genes to predict the prognosis of UCEC. Methods We a...

Full description

Bibliographic Details
Main Authors: Cankun Zhou, Chaomei Li, Fangli Yan, Yuhua Zheng
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-020-01560-w
_version_ 1819172445277388800
author Cankun Zhou
Chaomei Li
Fangli Yan
Yuhua Zheng
author_facet Cankun Zhou
Chaomei Li
Fangli Yan
Yuhua Zheng
author_sort Cankun Zhou
collection DOAJ
description Abstract Background Uterine corpus endometrial carcinoma (UCEC) is a frequent gynecological malignancy with a poor prognosis particularly at an advanced stage. Herein, this study aims to construct prognostic markers of UCEC based on immune-related genes to predict the prognosis of UCEC. Methods We analyzed expression data of 575 UCEC patients from The Cancer Genome Atlas database and immune genes from the ImmPort database, which were used for generation and validation of the signature. We constructed a transcription factor regulatory network based on Cistrome databases, and also performed functional enrichment and pathway analyses for the differentially expressed immune genes. Moreover, the prognostic value of 410 immune genes was determined using the Cox regression analysis. We then constructed and verified a prognostic signature. Finally, we performed immune infiltration analysis using TIMER-generating immune cell content. Results The immune cell microenvironment as well as the PI3K-Akt, and MARK signaling pathways were involved in UCEC development. The established prognostic signature revealed a ten-gene prognostic signature, comprising of PDIA3, LTA, PSMC4, TNF, SBDS, HDGF, HTR3E, NR3C1, PGR, and CBLC. This signature showed a strong prognostic ability in both the training and testing sets and thus can be used as an independent tool to predict the prognosis of UCEC. In addition, levels of B cells and neutrophils were significantly correlated with the patient’s risk score, while the expression of ten genes was associated with immune cell infiltrates. Conclusions In summary, the ten-gene prognostic signature may guide the selection of the immunotherapy for UCEC.
first_indexed 2024-12-22T20:07:18Z
format Article
id doaj.art-9b360f3f5dfe4d18a0394d08d68dab03
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-22T20:07:18Z
publishDate 2020-11-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-9b360f3f5dfe4d18a0394d08d68dab032022-12-21T18:14:07ZengBMCCancer Cell International1475-28672020-11-0120111710.1186/s12935-020-01560-wIdentification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinomaCankun Zhou0Chaomei Li1Fangli Yan2Yuhua Zheng3Department of Gynecology, Southern Medical University Affiliated Maternal & Child Health Hospital of FoshanDepartment of Obstetrics and Gynecology, Southern Medical University Affiliated Maternal & Child Health Hospital of FoshanDepartment of Gynecology, Shaoxing People’s HospitalDepartment of Gynecology, Southern Medical University Affiliated Maternal & Child Health Hospital of FoshanAbstract Background Uterine corpus endometrial carcinoma (UCEC) is a frequent gynecological malignancy with a poor prognosis particularly at an advanced stage. Herein, this study aims to construct prognostic markers of UCEC based on immune-related genes to predict the prognosis of UCEC. Methods We analyzed expression data of 575 UCEC patients from The Cancer Genome Atlas database and immune genes from the ImmPort database, which were used for generation and validation of the signature. We constructed a transcription factor regulatory network based on Cistrome databases, and also performed functional enrichment and pathway analyses for the differentially expressed immune genes. Moreover, the prognostic value of 410 immune genes was determined using the Cox regression analysis. We then constructed and verified a prognostic signature. Finally, we performed immune infiltration analysis using TIMER-generating immune cell content. Results The immune cell microenvironment as well as the PI3K-Akt, and MARK signaling pathways were involved in UCEC development. The established prognostic signature revealed a ten-gene prognostic signature, comprising of PDIA3, LTA, PSMC4, TNF, SBDS, HDGF, HTR3E, NR3C1, PGR, and CBLC. This signature showed a strong prognostic ability in both the training and testing sets and thus can be used as an independent tool to predict the prognosis of UCEC. In addition, levels of B cells and neutrophils were significantly correlated with the patient’s risk score, while the expression of ten genes was associated with immune cell infiltrates. Conclusions In summary, the ten-gene prognostic signature may guide the selection of the immunotherapy for UCEC.http://link.springer.com/article/10.1186/s12935-020-01560-wUterine corpus endometrial carcinomaTCGAImmune genePrognosis
spellingShingle Cankun Zhou
Chaomei Li
Fangli Yan
Yuhua Zheng
Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
Cancer Cell International
Uterine corpus endometrial carcinoma
TCGA
Immune gene
Prognosis
title Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
title_full Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
title_fullStr Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
title_full_unstemmed Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
title_short Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
title_sort identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
topic Uterine corpus endometrial carcinoma
TCGA
Immune gene
Prognosis
url http://link.springer.com/article/10.1186/s12935-020-01560-w
work_keys_str_mv AT cankunzhou identificationofanimmunegenesignatureforpredictingtheprognosisofpatientswithuterinecorpusendometrialcarcinoma
AT chaomeili identificationofanimmunegenesignatureforpredictingtheprognosisofpatientswithuterinecorpusendometrialcarcinoma
AT fangliyan identificationofanimmunegenesignatureforpredictingtheprognosisofpatientswithuterinecorpusendometrialcarcinoma
AT yuhuazheng identificationofanimmunegenesignatureforpredictingtheprognosisofpatientswithuterinecorpusendometrialcarcinoma